Dr. Moran Amit, MD

Dr. Amit practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Amit's NPI, 1477040335, was assigned on April 17, 2018. Dr. Amit graduated from Tel Aviv University Sackler in 2007. Dr. Amit holds Texas license S1750.

Dr. Amit's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Amit's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Amit practices. Vendor and product names are available with a free account.

Otolaryngology is Dr. Amit's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dmand AI has Dr. Amit's licenses on file in 3 states: Texas, Florida and Illinois.

Dmand AI lists larynx and vocal cord disease among the conditions Dr. Amit treats.

CMS data shows 78 Medicare services from Dr. Amit across 3 procedure codes in 2024, all of them office visits, for 56 Medicare patients. Medicare paid $7,486 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 56 Medicare patients who saw Dr. Amit in 2024. The largest group is 65 to 74, with 31 patients. 75% of them have high blood pressure, and 71% have high cholesterol. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Amit's median patient age at 73, with 39% women.

In 2024, Dr. Amit wrote 26 Medicare Part D claims for 12 patients. 96% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Amit for performance year 2024, reported as part of a group. Dr. Amit accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 189 papers to Dr. Amit, published from 2010 to 2025. 2020 was the busiest year, with 25. The most frequent topics are Neoplasm Invasiveness, Carcinoma, Squamous Cell and Mouth Neoplasms. Dr. Amit has published most often in Head Neck. Dr. Amit's most frequent co-authors are Samantha Tam, Yoav Binenbaum, MD, PhD and Neil Dwayne Gross, MD.

Dmand AI links Dr. Amit to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Anxiety Disorders, Head and Neck Neoplasms and Depression. M.D. Anderson Cancer Center sponsors the most, 2.

CMS Open Payments shows 4 general payments to Dr. Amit from 3 drug and device companies from 2018 to 2019. Food and beverage make up the largest share, 100% of the total. Acclarent, Inc paid the most, $52.

Dr. Amit graduated from Tel Aviv University Sackler in 2007.

Dr. Amit is in network with 5 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 4. Check the plan with the practice before a visit.